Toggle navigation

FIND A TREATMENT CENTER NEAR YOU

Use this locator resource to help you find a treatment center close to you that might be able to administer SPINRAZA

Emma
age 7

Later-onset (Type 3) SMA
treated with SPINRAZA

SMA patient find a treatment center

SPINRAZA is given through a procedure called intrathecal injection and can only be done at designated treatment centers by or under the direction of a qualified healthcare provider (HCP).

Type in your ZIP code below and click “Find Location” to see a list of treatment facilities that are close to you and have chosen to be listed. You can sort the results by centers that treat children and/or adults with spinal muscular atrophy (SMA). Before choosing a location, talk to your primary HCP.

The locator tool is frequently updated, so be sure to check back and see if there are any new treatment centers in your area.

Treatment Center Locations

Biogen does not receive payment for this service and does not endorse or recommend any treatment center. Further, Biogen does not have oversight of and is not responsible for the actions of any treatment center.

Biogen does not guarantee availability at any particular treatment center. Every individual is unique and only after careful medical evaluation can a course of treatment be determined.

You are ultimately responsible for the selection of a treatment center and it is an important decision that you should consider carefully. Your HCP is your primary resource and should be consulted as you use this locator tool. 

Here are some questions that may help you choose a treatment center:

Are you currently accepting new patients?

Do you treat individuals with SMA across all ages and SMA types?

Does my health insurance cover the costs for the SPINRAZA treatment procedure at your center?

Do you have experience treating SMA patients with medical complexities/complications, such as growing rods, spinal fusion, etc?

How long does it take to get an initial appointment to discuss SPINRAZA treatment?

Click here to download a discussion guide to refer to once you've found a treatment center.

IMPORTANT SAFETY INFORMATION

Increased risk of bleeding complications has been observed after administration of similar medicines. Your healthcare provider should perform blood tests before you start treatment with SPINRAZA and before each dose to monitor for signs of these risks. Seek medical attention if unexpected bleeding occurs.

Increased risk of kidney damage, including potentially fatal acute inflammation of the kidney, has been observed after administration of similar medicines. Your healthcare provider should perform urine testing before you start treatment with SPINRAZA and before each dose to monitor for signs of this risk.

The most common side effects of SPINRAZA include lower respiratory infection, fever, constipation, headache, vomiting, back pain, and post-lumbar puncture syndrome.

These are not all of the possible side effects of SPINRAZA. Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information for additional Important Safety Information.

As a courtesy, our full Prescribing Information is also available en Español. For prescribing decisions, please refer to official approved labeling.

This information is not intended to replace discussions with your healthcare provider.


INDICATION

SPINRAZA is a prescription medicine used to treat spinal muscular atrophy (SMA) in pediatric and adult patients.